Trade Vericel Corp - VCEL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.14 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023624% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001401% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 43.02 |
| Open | 42.52 |
| 1-Year Change | -19.47% |
| Day's Range | 42.52 - 44.67 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | 43.02 | -0.94 | -2.14% | 43.96 | 44.21 | 42.49 |
| Mar 31, 2025 | 44.51 | 1.22 | 2.82% | 43.29 | 44.63 | 42.48 |
| Mar 28, 2025 | 44.41 | -0.84 | -1.86% | 45.25 | 45.71 | 44.04 |
| Mar 27, 2025 | 45.90 | -0.49 | -1.06% | 46.39 | 46.50 | 45.32 |
| Mar 26, 2025 | 46.35 | -1.08 | -2.28% | 47.43 | 47.43 | 46.04 |
| Mar 25, 2025 | 47.91 | 0.63 | 1.33% | 47.28 | 48.47 | 47.06 |
| Mar 24, 2025 | 47.84 | 1.39 | 2.99% | 46.45 | 48.30 | 46.45 |
| Mar 21, 2025 | 46.21 | 0.86 | 1.90% | 45.35 | 47.06 | 44.98 |
| Mar 20, 2025 | 47.11 | 0.16 | 0.34% | 46.95 | 47.60 | 45.57 |
| Mar 19, 2025 | 47.37 | 1.42 | 3.09% | 45.95 | 47.45 | 45.53 |
| Mar 18, 2025 | 46.26 | -0.62 | -1.32% | 46.88 | 47.38 | 45.79 |
| Mar 17, 2025 | 47.54 | 2.40 | 5.32% | 45.14 | 47.73 | 45.14 |
| Mar 14, 2025 | 45.29 | -0.07 | -0.15% | 45.36 | 47.05 | 45.01 |
| Mar 13, 2025 | 45.34 | 0.20 | 0.44% | 45.14 | 46.25 | 45.14 |
| Mar 12, 2025 | 45.71 | -1.42 | -3.01% | 47.13 | 48.05 | 45.26 |
| Mar 11, 2025 | 47.69 | -1.26 | -2.57% | 48.95 | 48.95 | 46.80 |
| Mar 10, 2025 | 48.81 | -0.02 | -0.04% | 48.83 | 49.00 | 47.36 |
| Mar 7, 2025 | 49.41 | 1.08 | 2.23% | 48.33 | 50.21 | 47.05 |
| Mar 6, 2025 | 48.68 | -1.15 | -2.31% | 49.83 | 51.17 | 48.66 |
| Mar 5, 2025 | 51.47 | 0.94 | 1.86% | 50.53 | 51.80 | 50.43 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Vericel Corp Ord Company profile
About Vericel Corp
Vericel Corporation is a commercial-stage biopharmaceutical company. The Company specializes in cell therapies and specialty biologics for the sports medicine and severe burn care. It operates in one reportable segment, the research, product development, manufacture, and distribution of cellular therapies for use in the treatment of specific diseases. It markets two autologous cell therapy products in the United States, which includes MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The MACI is an autologous cellularized scaffold product indicated for the repair of symptomatic, single, or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. The Epicel is a permanent skin replacement humanitarian use device (HUD) for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area (TBSA).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Vericel Corp revenues increased 26% to $156.2M. Net loss totaled $7.5M vs. income of $2.9M. Revenues reflect MACI segment increase of 18% to $111.6M, Epicel segment increase of 51% to $41.5M. Net loss reflects Stock-based Compensation in SGA increase from $10M to $26.5M (expense), Other Selling , General Expense increase of 21% to $71.1M (expense).
Equity composition
Common Stock no Par, 3/11, 62.5M auth., 38,618,037 issd. Insiders control approx. 0.63%. IPO: 2/97, 3M shares @ $7 byCowen & Company. 02/10 1-for-8 reverse split. 10/13, 1-for-20 Reverse Stock split.
| Industry: | Biopharmaceuticals |
64 Sidney St
CAMBRIDGE
MASSACHUSETTS 02139-4170
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com